ANZCA Primary
Physiology
Thermoregulation
High Evidence

Temperature Regulation

Temperature regulation maintains core temperature 36.5-37.5°C through balance of heat production, conservation, and loss, regulated by the hypothalamus. Heat production: Basal metabolic rate (BMR, 80 W at rest),...

Updated 2 Feb 2026
2 min read
Citations
74 cited sources
Quality score
51 (gold)

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Urgent signals

Safety-critical features pulled from the topic metadata.

  • Malignant hyperthermia (rapid temperature rise >38.8°C)
  • Severe hypothermia <32°C with arrhythmias
  • Heat stroke with core temperature >40°C
  • Hypothermia-induced coagulopathy

Exam focus

Current exam surfaces linked to this topic.

  • ANZCA Primary Written
  • ANZCA Primary Viva

Editorial and exam context

ANZCA Primary Written
ANZCA Primary Viva

Topic family

This concept exists in multiple MedVellum libraries. Use the primary page for the broadest reference view and the others for exam-specific framing.

Clinical reference article

Quick Answer

Temperature regulation maintains core temperature 36.5-37.5°C through balance of heat production, conservation, and loss, regulated by the hypothalamus. Heat production: Basal metabolic rate (BMR, 80 W at rest), muscle activity (shivering increases heat production 2-5×), thermogenic hormones (thyroxine, catecholamines), brown fat metabolism (neonates). Heat loss: Radiation (60%, infrared emission), convection (15%, air currents), conduction (3%, direct contact), evaporation (22%, sweating, respiration); regulated by skin blood flow (vasodilation/vasoconstriction) and sweating. Hypothalamic regulation: Preoptic anterior hypothalamus (POAH) contains temperature-sensitive neurons; set point maintained; deviation triggers responses: cold—shivering, piloerection, peripheral vasoconstriction; heat—vasodilation, sweating, behavioral responses. Anaesthetic effects: General anaesthetics impair hypothalamic regulation and abolish behavioral responses; vasodilation promotes heat loss; patients cannot shiver under GA; hypothermia (core temperature <36°C) occurs in 50-90% of surgical patients without active warming; phases—redistribution (first hour, core heat moves to periphery due to vasodilation), linear decline (continued heat loss exceeding production), plateau (thermal equilibrium if heat loss equals production). Complications of hypothermia: Increased surgical site infection (impaired immune function), coagulopathy (platelet dysfunction, enzyme inhibition—each 1°C drop reduces coagulation factor activity 10%), increased blood loss, prolonged drug action (reduced hepatic metabolism), shivering in PACU (increases oxygen consumption 200-500%, myocardial stress), thermal discomfort, delayed wound healing. Prevention: Forced air warming (most effective—Bair Hugger, reduces heat loss, can add heat), warmed IV fluids (minimal effect unless large volumes), increased ambient temperature (OR to 24-26°C initially then lower to 21-22°C), circulating water mattresses, radiant warmers (neonates). Malignant hyperthermia: Pharmacogenetic disorder triggered by volatile agents and suxamethonium; uncontrolled hypermetabolism in skeletal muscle; temperature rises late (not early sign); early signs—tachycardia, tachypnea, increased CO₂, rigidity; treatment—dantrolene 2.5 mg/kg IV (inhibits Ca²⁺ release from sarcoplasmic reticulum), cooling, supportive care. Hypothermia treatment: Gradual rewarming; active external (forced air, warm blankets), active internal (warmed IV fluids, body cavity lavage, cardiopulmonary bypass if severe); avoid rapid rewarming (risk of arrhythmias, afterdrop—core temperature continues to fall after rewarming starts due to cold blood returning from periphery). Therapeutic hypothermia: 32-34°C for 24 hours post-cardiac arrest (neuroprotection); targeted temperature management. Indigenous populations: Higher rates of obesity and metabolic syndrome; careful temperature monitoring and active warming essential. [1-10]